[{"address1": "302 East Pettigrew Street", "address2": "Suite A-100", "city": "Durham", "state": "NC", "zip": "27701", "country": "United States", "phone": "919 314 5512", "fax": "480 393 5553", "website": "https://www.precisionbiosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision in the United States. It offers ARCUS, a genome editing platform to DNA genome insertion, deletion, and repair. The company also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; PBGENE-PMM for the treatment of m.3243 associated primary mitochondrial myopathy (PMM) which is expected to submit an IND and/or CTA. In addition, it develops PBGENE-NVS for sickle cell disease/beta thalassemia for insertion; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. The company has license and collaboration agreement with Caribou Biosciences, Inc.; license agreement with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; Cellectis S.A.; iECURE, Inc. to develop ARCUS-based gene-insertion therapies; Duke University; and Novartis Pharma AG to discover and develop in vivo gene editing products. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.", "fullTimeEmployees": 108, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael  Amoroso", "age": 46, "title": "President, CEO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1094351, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jefferson J. Smith Ph.D.", "age": 51, "title": "Co-Founder & Chief Research Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 640195, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Alexander Kelly R.Ph.", "age": 57, "title": "CFO & Principal Accounting Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 671382, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cassie  Gorsuch Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Naresh  Tanna", "title": "Chief of Staff to CEO & Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dario  Scimeca J.D.", "age": 48, "title": "General Counsel & Secretary", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 576432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Juli  Blanche", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cindy  Atwell", "title": "Chief Development & Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil  Leatherbury M.S.", "title": "Senior VP and Head of Chemistry, Manufacturing & Controls", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Murray  Abramson M.D., M.P.H.", "title": "Senior VP & Head of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.5, "open": 5.5055, "dayLow": 5.22, "dayHigh": 5.6761, "regularMarketPreviousClose": 5.5, "regularMarketOpen": 5.5055, "regularMarketDayLow": 5.22, "regularMarketDayHigh": 5.6761, "payoutRatio": 0.0, "beta": 1.584, "trailingPE": 5.125, "forwardPE": -0.7861357, "volume": 69321, "regularMarketVolume": 69321, "averageVolume": 151428, "averageVolume10days": 198920, "averageDailyVolume10Day": 198920, "bid": 5.17, "ask": 5.39, "bidSize": 1, "askSize": 1, "marketCap": 58025044, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 13.436, "priceToSalesTrailing12Months": 0.8446641, "fiftyDayAverage": 5.083, "twoHundredDayAverage": 7.100925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -398307, "profitMargins": 0.104329996, "floatShares": 8756605, "sharesOutstanding": 10550100, "sharesShort": 652187, "sharesShortPriorMonth": 618279, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0618, "heldPercentInsiders": 0.09403, "heldPercentInstitutions": 0.46488997, "shortRatio": 2.77, "shortPercentOfFloat": 0.0639, "impliedSharesOutstanding": 10886500, "bookValue": 6.875, "priceToBook": 0.7752727, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": 7167000, "trailingEps": 1.04, "forwardEps": -6.78, "lastSplitFactor": "1:30", "lastSplitDate": 1707868800, "enterpriseToRevenue": -0.006, "enterpriseToEbitda": 0.018, "52WeekChange": -0.4583333, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 5.33, "targetHighPrice": 60.0, "targetLowPrice": 13.0, "targetMeanPrice": 29.4, "targetMedianPrice": 25.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 86312000, "totalCashPerShare": 8.234, "ebitda": -22758000, "totalDebt": 30045000, "quickRatio": 5.875, "currentRatio": 6.341, "totalRevenue": 68696000, "debtToEquity": 53.278, "revenuePerShare": 10.054, "returnOnAssets": -0.110419996, "returnOnEquity": 0.19047001, "grossProfits": 68696000, "freeCashflow": -2337000, "operatingCashflow": -58445000, "grossMargins": 1.0, "ebitdaMargins": -0.33129, "operatingMargins": -38.94357, "financialCurrency": "USD", "symbol": "DTIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Precision BioSciences, Inc.", "longName": "Precision BioSciences, Inc.", "postMarketChangePercent": 3.00187, "postMarketPrice": 5.49, "postMarketChange": 0.16, "regularMarketChange": -0.17000008, "regularMarketDayRange": "5.22 - 5.6761", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 151428, "fiftyTwoWeekLowChange": 1.72, "fiftyTwoWeekLowChangePercent": 0.47645432, "fiftyTwoWeekRange": "3.61 - 13.436", "fiftyTwoWeekHighChange": -8.106, "fiftyTwoWeekHighChangePercent": -0.60330456, "fiftyTwoWeekChangePercent": -45.833332, "earningsTimestamp": 1742986860, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 1.04, "epsForward": -6.78, "epsCurrentYear": -10.22, "priceEpsCurrentYear": -0.5215264, "fiftyDayAverageChange": 0.24699974, "fiftyDayAverageChangePercent": 0.048593298, "twoHundredDayAverageChange": -1.770925, "twoHundredDayAverageChangePercent": -0.24939357, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1553779800000, "corporateActions": [], "postMarketTime": 1745615205, "regularMarketTime": 1745611202, "exchange": "NCM", "messageBoardId": "finmb_41018856", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.0909104, "regularMarketPrice": 5.33, "displayName": "Precision BioSciences", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]